Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
11/10/2005 | WO2005105723A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
11/10/2005 | WO2005105065A2 Thiazole-based nitric oxide donors for treating inflammatory bowel diseases |
11/10/2005 | WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors |
11/10/2005 | US20050250944 Synthesis and uses of synephrine derivatives |
11/10/2005 | US20050250824 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
11/10/2005 | US20050250822 Substituted benzanilide compound and noxious organism controlling agent |
11/10/2005 | US20050250820 Therapeutic modulation of PPARgamma activity |
11/10/2005 | US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor |
11/10/2005 | US20050250786 PNA monomer and precursor |
11/10/2005 | US20050250785 PNA monomer and precursor |
11/10/2005 | US20050250777 Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
11/10/2005 | US20050250776 ethyl (2-{[(2,4-dichloro-5-methylphenyl)sulfonyl]amino}-1,3-thiazol-5-yl)acetate; treatment of diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, without causing hypoglycemia |
11/10/2005 | US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
11/10/2005 | US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
11/10/2005 | US20050250152 fluorescent derivatization reagents that label substances containing aldehydes, ketones, and similar functional groups, and their use in labeling glycoproteins and glycopeptides, nucleic acids and lipopolysaccharides, and other biomolecules |
11/10/2005 | CA2566369A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
11/10/2005 | CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
11/10/2005 | CA2563443A1 Therapeutic formulations of desoxyepothilones |
11/10/2005 | CA2555862A1 Polyamine analogs that activate antizyme frameshifting |
11/09/2005 | EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
11/09/2005 | EP1593307A2 Agents for combatting plant pests |
11/09/2005 | EP1592403A1 Aqueous dispersion comprising stable nanoparticles of a water-insoluble thiazole derivative and excipients like middle chain triglycerides |
11/09/2005 | EP1456202B1 Benzothiazoles |
11/09/2005 | EP1411935A4 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
11/09/2005 | EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds |
11/09/2005 | EP1216223B1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
11/09/2005 | EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
11/09/2005 | EP1019389B1 Epothilone derivatives |
11/09/2005 | EP0873326B1 Process for preparing 2-chlorothiazole compounds |
11/09/2005 | CN1694873A Vanilloid receptor ligands and their use in treatments |
11/09/2005 | CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma |
11/09/2005 | CN1226294C Fused heteroaromatic glucokinase activators |
11/09/2005 | CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide |
11/08/2005 | US6963000 Benzothiazole derivatives with activity as adenosine receptor ligands |
11/08/2005 | US6962935 Anticoagulants; thrombosis therapy; cardiovascular disorders |
11/08/2005 | CA2373834C A process for the production of thiazolidine |
11/08/2005 | CA2256085C Association of procysteine with a polyol |
11/08/2005 | CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors |
11/03/2005 | WO2005103022A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators |
11/03/2005 | WO2005103021A1 Tri(cyclo) substituted amide compounds |
11/03/2005 | WO2005103013A1 Therapeutic agent for nonviral hepatitis |
11/03/2005 | WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof |
11/03/2005 | WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
11/03/2005 | WO2004099165A3 Heterocyclic compounds and hydro isomers thereof |
11/03/2005 | US20050245602 Selective estrogen receptor modulators |
11/03/2005 | US20050245579 desferrithiocin analogs used as siderophores, for treatment of malaria in humans |
11/03/2005 | US20050245573 N-substituted benzene sulfonamides |
11/03/2005 | US20050245542 Pyridazine, pyrimidine and pyrazine ethyne compounds |
11/03/2005 | US20050245534 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
11/03/2005 | US20050245525 Compounds useful for inhibiting CHK1 |
11/03/2005 | US20050245512 Method and composition for rejuvinating cells, tissues organs, hair and nails |
11/03/2005 | US20050245432 N-methyl amino acids |
11/03/2005 | CA2563192A1 Tri(cyclo) substituted amide compounds |
11/02/2005 | EP1590340A1 Inhibitors of histone deacetylase |
11/02/2005 | EP1590337A1 Acylaminothiazole derivatives, preparation method thereof and use of same as beta-amyloid peptide production inhibitors |
11/02/2005 | EP1589967A1 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
11/02/2005 | EP1507530B1 Diaminothiazoles and use thereof as cdk4 inhibitors |
11/02/2005 | EP1446402B1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase |
11/02/2005 | EP1196371B1 Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
11/02/2005 | EP1005493B1 Antiviral protease inhibitors |
11/02/2005 | EP0946531B1 Process for the preparation of thiazole derivatives |
11/02/2005 | CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus |
11/02/2005 | CN1692108A Pesticidal heterocycles |
11/02/2005 | CN1690051A Novel azoles having an insecticidal action |
11/02/2005 | CN1225471C Compounds with growth hormone releasing properties |
11/02/2005 | CN1225462C New piperazine and piperidine compounds |
11/01/2005 | US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity |
11/01/2005 | US6960664 Aza hydroxylated ethyl amine compounds |
11/01/2005 | US6960606 Adamantyl Thiazole Thioureas |
11/01/2005 | US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
11/01/2005 | US6960604 Thyroid receptor ligands |
11/01/2005 | US6960591 Propane-1,3-dione derivative |
10/27/2005 | WO2005100332A1 Dat1 |
10/27/2005 | WO2005100331A2 Antidiabetic agents |
10/27/2005 | WO2005100330A1 Preparation of intermediate for 3-[2-(4-methylthiazole-5-yl)vinyl] cephalosporins |
10/27/2005 | WO2005100329A1 Novel protecting reagents, protecting groups and methods of forming and using the same |
10/27/2005 | WO2005100318A1 Alkanoic acids and their esters as antidiabetic agents |
10/27/2005 | WO2005100303A1 Indene derivatives and process for the preparation thereof |
10/27/2005 | WO2005100301A1 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors |
10/27/2005 | WO2005090295A3 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |
10/27/2005 | US20050240023 Cathepsin cysteine protease inhibitors |
10/27/2005 | US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents |
10/27/2005 | US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
10/27/2005 | US20050239853 New compounds |
10/27/2005 | US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
10/27/2005 | US20050239851 Substituted benzoxazoles as estrogenic agents |
10/27/2005 | US20050239849 Substituted phenoxyacetic acids |
10/27/2005 | US20050239839 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
10/27/2005 | US20050239691 Cross-linked glycopeptide - cephalosporin antibiotics |
10/27/2005 | US20050238677 Multi-lamellar liquid crystal emulsion system |
10/27/2005 | US20050238614 Polyethylene glycol conjugates of heterocycloalkyl carboxamido propanoic acids |
10/27/2005 | DE102004016845A1 Phenylthioessigsäure-Derivate und ihre Verwendung Phenylthioacetic acid derivatives and their use |
10/26/2005 | EP1589017A2 12,13-modified epothilone derivatives |
10/26/2005 | EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments |
10/26/2005 | EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents |
10/26/2005 | EP1587800A1 Thiazole derivatives and their use as vap-1 inhibitors |
10/26/2005 | EP1587547A2 Amyloid-binding, metal-chelating agents |
10/26/2005 | EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators |
10/26/2005 | EP1183229B1 Glucagon antagonists/inverse agonists |
10/26/2005 | EP0973727B1 Activated iododerivatives for the treatment of cancer and aids |